Guardant Health, Inc. (GH) Q4 2022 Earnings Results

Guardant Health Inc Misses on EPS, Stock Down 6.51%

Guardant Health's earnings report shows a mixed performance with a notable EPS miss, although it exceeded expectations slightly. The stock reacted negatively, dropping 6.51%, likely due to the lack of revenue data and cautious management commentary. Investors may be concerned about the company's future prospects without clear guidance.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$-1.17	N/A	+16.67%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Defensive

Management expressed caution regarding future performance. They highlighted the need for strategic adjustments in response to market conditions.

Management did not provide specific revenue guidance for the upcoming quarters.

The company acknowledged ongoing challenges in the market.

Guardant Health Inc Misses on EPS, Stock Down 6.51%

Key numbers

Management commentary

Guardant Health, Inc.

More earnings this week

Guardant Health Inc Misses on EPS, Stock Down 6.51%

Key numbers

Management commentary